Key regions: Canada, United States, Australia, Brazil, Japan
The Digestives & Intestinal Remedies market in EU-27 is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.
Customer preferences: Customers in the EU-27 region are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This shift in preference is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. Additionally, there is a rising demand for products that address specific digestive concerns, such as bloating, indigestion, and irritable bowel syndrome. Customers are also looking for convenient and easy-to-use formats, such as chewable tablets or liquid supplements.
Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in the EU-27 is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for gut health. They help restore the natural balance of bacteria in the digestive system, improving digestion and reducing symptoms of digestive disorders. The increasing awareness of the importance of gut health and the benefits of probiotics has led to a surge in demand for probiotic supplements and foods across the region.Another trend in the market is the rising popularity of fermented foods and beverages. Fermented products, such as yogurt, sauerkraut, and kombucha, contain beneficial bacteria that promote a healthy gut. These products are not only seen as a tasty addition to meals but also as a way to improve digestion and overall well-being. As a result, there has been a growing demand for fermented food and beverage products in the EU-27 region.
Local special circumstances: The EU-27 region has a diverse population with varying dietary habits and lifestyles. This diversity creates opportunities for companies to cater to specific dietary needs and preferences. For example, there is a growing demand for gluten-free and lactose-free digestive remedies to accommodate individuals with food intolerances. Additionally, the region has a significant aging population, which is more prone to digestive issues. This demographic trend presents an opportunity for companies to develop products tailored to the needs of older consumers.
Underlying macroeconomic factors: The Digestives & Intestinal Remedies market in the EU-27 is influenced by several macroeconomic factors. One of the key drivers is the increasing healthcare expenditure in the region. As disposable incomes rise and healthcare becomes more accessible, consumers are willing to spend more on preventive and alternative healthcare products. Additionally, the aging population in the EU-27 region is expected to drive the demand for digestive remedies, as older individuals are more likely to experience digestive issues.Furthermore, the regulatory environment in the EU-27 region plays a significant role in shaping the Digestives & Intestinal Remedies market. The European Union has strict regulations regarding the safety and efficacy of healthcare products, including digestive remedies. These regulations ensure that products meet high-quality standards and provide consumers with safe and effective solutions for their digestive health needs.In conclusion, the Digestives & Intestinal Remedies market in the EU-27 is experiencing growth due to changing customer preferences, emerging trends such as the popularity of probiotics and fermented foods, local special circumstances such as diverse dietary needs and an aging population, and underlying macroeconomic factors including increasing healthcare expenditure and strict regulatory standards.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
